Adams Street Partners operates as a global private market investment management firm.
Business Model:
Revenue: $10M
Employees: 201-500
Address: 1 N Wacker Dr
City: Chicago
State: IL
Zip: 60606
Country: US
Adams Street Partners is a global private market investment management firm that offers comprehensive solutions for its investors. As one of the independent, employee-owned firms, Adams Street has established a reputation for strong performance, an extensive knowledge base, and a disciplined investment approach that values quality over quantity. For more than 45 years, Adams Street has gained the experience to successfully manage through some of the most challenging investment cycles. The collective knowledge of the Adams Street team works collaboratively to leverage the global resources of the Firm in navigating the complexities of private markets. Its mission as a premier private markets investment manager is to provide world-class investment performance and maintain the confidence of our investors through our deep understanding of the global private marketplace and deliver exemplary client service.
Contact Phone:
+13125537890
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2002 | CBeyond | Venture Round | - |
9/2015 | Cybera | Private Equity Round | - |
8/2016 | LogRhythm | Venture Round | 50M |
8/2013 | CareCloud Corporation | Series B | 9M |
6/2001 | SPS Commerce | Series D | 10M |
5/2017 | Snow Software | Venture Round | - |
1/2017 | Included Health (previously Grand Rounds Health and Doctor On Demand) | Venture Round | - |
10/2019 | Icosavax | Series A | 0 |
4/2012 | Neuraltus Pharmaceuticals | Venture Round | 0 |
3/2006 | RadPharm | Series A | 8M |
1/2010 | magicJack | Venture Round | - |
5/2007 | ShermansTravel Media, LLC | Private Equity Round | 14M |
1/2018 | Therapy Brands | Venture Round | - |
5/2009 | Peerless Network | Venture Round | 10.1M |
5/2009 | Revascular Therapeutics | Series B | 3M |
1/2016 | Skybox Security | Venture Round | - |
8/2015 | Orbus Therapeutics | Series A | 32.5M |
3/2007 | WhiteFence | Series B | 0 |
5/2008 | Paylocity | Venture Round | 10M |
12/2013 | Bluprint | Series C | 35M |
5/2013 | Five9 | Series D | 22M |
12/2005 | Light Sciences Oncology | Series A | 32M |
5/2019 | SymphonyRM | Series A | 10M |
2/2018 | Partner Therapeutics | Series A | 60M |
1/2007 | DolEx Dollar Express | Venture Round | - |
7/2011 | Jaspersoft | Unattributed | 11M |
7/2019 | TurnKey Vacation Rentals | Series E | 48M |
11/2006 | MX Logic | Series F | 4M |
2/2006 | Aesthera Corporation | Series C | 11M |
6/2009 | Integral Development Corp | Venture Round | 11M |
2/2014 | Spiceworks, Inc. | Series E | 57M |
1/2007 | Actelis Networks | Series E | 22M |
4/2011 | Spiceworks, Inc. | Series D | 25M |
10/2013 | Mintigo | Series C | 10M |
9/2008 | Sportgenic | Series B | 10M |
6/2007 | WiQuest Communications | Series C | 28M |
4/2007 | Cybera | Series C | 18M |
9/2019 | VillageMD | Series B | 100M |
3/2021 | Advise Health | Series A | 100M |
11/2011 | BrightRoll | Series D | 20.3M |
6/2014 | Couchbase | Series E | 60M |
3/2016 | Couchbase | Series F | 30M |
9/2012 | Damballa | Series E | 15M |
5/2017 | Mintigo | Series E | 0 |
7/2022 | ClassDojo | Series D | 125M |
5/2016 | Aptinyx | Series A | 0 |
12/2006 | Setanta | Private Equity Round | 0 |
5/2020 | Palvella Therapeutics | Series C | 0 |
1/2007 | Ancestry | Funding Round | - |
5/2021 | SymphonyRM | Series B | 0 |
9/2010 | Solaria | Series D | 65M |
7/2014 | LogRhythm | Series E | 40M |
4/2021 | ThreatQuotient | Venture Round | 0 |
8/2013 | CareCloud | Series B | 9M |
3/2004 | Jazz Pharmaceuticals | Series B | 0 |
11/2016 | CareCloud | Post-IPO Equity | 0 |
1/2004 | Borderfree | Series C | 13.8M |
6/2001 | Quallaby Corporation | Venture Round | 14.5M |
1/1999 | Syneos Health | Venture Round | - |
8/2021 | Reify Health | Series C | 220M |
8/2007 | Luminary Micro | Series C | 25M |
4/2023 | Altruist | Series D | 0 |
12/2022 | BillionToOne | Series C | 0 |
10/2010 | TriReme Medical | Series D | 17M |
6/2004 | Proteus Digital Health | Series B | 6.3M |
1/2002 | Synchronoss Technologies | Series A | 0 |
5/2001 | Synchronoss Technologies | Series A | 0 |
6/2022 | FalconX | Series D | 0 |
5/2020 | Couchbase | Series G | 0 |
1/2007 | TicketsNow | Series A | 34M |
12/2008 | Jaspersoft | Venture Round | 12.5M |
4/2014 | Telesign | Series B | 40M |
7/2020 | Robinhood | Series F | 0 |
10/2018 | Qpex Biopharma | Series A | 33M |
11/2017 | Outpost Medicine, LLC | Series A | 20M |
5/2001 | Netcontinuum | Series B | 26M |
8/2003 | comScore | Series E | 12M |
12/2005 | GlobeImmune | Series B | 34.3M |
12/2015 | CBANC | Series B | 4M |
1/2012 | Neuraltus Pharmaceuticals | Series B | 9.6M |
4/2021 | Mineralys Therapeutics | Series A | 0 |
1/2011 | PneumRx | Venture Round | 0 |
12/2016 | Tripping.com | Series C | 0 |
5/2013 | Atlantis Computing | Series D | 0 |
1/2019 | Millennium Trust Co | Venture Round | - |
6/2015 | RadiumOne | Series C | 54M |
8/2013 | Couchbase | Series D | 25M |
10/2006 | Enfora | Venture Round | 19M |
11/2009 | Zynga | Venture Round | - |
3/2011 | RadiumOne | Series B | 31.5M |
5/2017 | Smule | Series H | 54M |
12/2012 | Naurex | Series B | 0 |
5/2010 | Arroweye Solutions | Private Equity Round | 8.4M |
3/2016 | Maxwell Health | Series C | 0 |
5/2019 | Solera Health | Series C | 0 |
4/2019 | Fusion Pharmaceuticals | Series B | 0 |
6/2016 | Smule | Series G | 0 |
8/2003 | Engim | Series B | 18.5M |
12/2017 | Aptinyx | Series B | 70M |
12/2014 | Maxwell Health | Series B | 26.4M |
3/2007 | PneumRx | Series B | 0 |
5/2020 | Aircall | Series C | 0 |
10/2021 | Orca Security | Series C | 0 |
5/2003 | SPS Commerce | Venture Round | 18M |
9/2009 | RadiumOne | Series A | 2M |
8/2014 | Scytl | Series C | 44M |
10/2018 | Arctic Wolf | Series C | 45M |
7/2004 | Convio | Series D | 15M |
6/2021 | Aircall | Series D | 0 |
5/2007 | Convio | Series E | 10.2M |
9/2015 | Corvus Pharmaceuticals | Series B | 75M |
11/2011 | Rempex Pharmaceuticals | Series B | 67.5M |
9/2014 | BoomTown | Series A | 20.1M |
2/2021 | Redox | Series D | 45M |
1/2006 | MX Logic | Series E | 6.5M |
12/2007 | MX Logic | Series G | 2.7M |
11/2008 | MX Logic | Series G | 5.7M |
4/2008 | Visible World | Series C | 25M |
1/2011 | Five9 | Series C | 8.6M |
11/2008 | Arroweye Solutions | Private Equity Round | 23.5M |
4/2012 | Five9 | Venture Round | 12M |
2/2008 | Snagajob | Series B | 5M |
3/2014 | ThreatMetrix | Series E | 20M |
11/2016 | TrendKite | Series D | 16.3M |
11/2008 | OncoMed Pharmaceuticals | Series B | 154M |
7/2002 | Sensys Medical | Series D | 0 |
2/2010 | BrightRoll | Series C | 10M |
2/2019 | PerimeterX | Series C | 43M |
6/2015 | Chrome River Technologies | Series D | 100M |
11/2011 | Pivot Medical | Series C | 32M |
5/2020 | Homeward | Series A | 20M |
12/2014 | Naurex | Series C | 0 |
5/2007 | Arroweye Solutions | Series C | 14M |
10/2007 | TriReme Medical | Series C | 15.5M |
5/2021 | Homeward | Series B | 136M |
4/2017 | Cirius Therapeutics | Series A | 0 |
2/2005 | Aesthera Corporation | Series B | 6.5M |
8/2015 | Apto | Series B | 8M |
3/2017 | TurnKey Vacation Rentals | Series C | 21M |
3/2018 | TurnKey Vacation Rentals | Series D | 31M |
7/2006 | Snagajob | Series A | 9M |
6/2014 | Visier | Series C | 25.5M |
6/2017 | MyHealthTeams | Series A | 7.3M |
6/2022 | Mineralys Therapeutics | Series B | 0 |
7/2011 | Adesto Technologies | Series C | 17.4M |
12/2017 | Atox Bio | Series F | 0 |
2/2018 | Cofense | Venture Round | - |
9/2019 | PerimeterX | Series C | 0 |
3/2003 | Livevault | Series B | 10M |
6/2012 | LogRhythm | Series D | 15M |
3/2011 | LogRhythm | Series C | 10M |
9/2021 | Nomad Health | Series D | 0 |
9/2004 | MX Logic | Series D | 8M |
5/2004 | PathScale | Series C | 15M |
12/2019 | Epirium Bio | Series A | 0 |
9/2009 | Actelis Networks | Venture Round | 0 |
5/2012 | Cybera | Venture Round | 4.4M |
1/2007 | FarmLink | Venture Round | 0 |
3/2016 | Outpost Medicine | Series A | 41M |
1/2012 | Donuts | Series A | 0 |
2/2019 | GoCardless | Series E | 75M |
8/2018 | Cirius Therapeutics | Series A | 9M |
2/2017 | Scytl | Series D | 13M |
11/2019 | Punchh | Series C | 40M |
7/2017 | Lever | Series C | 40M |
2/2014 | MyHealthTeams | Series A | 3.4M |
8/2021 | Hopin | Series D | 0 |
2/2002 | Livevault | Venture Round | 8M |
8/2001 | comScore | Series C | 15M |
9/2003 | Quallaby Corporation | Series E | 5M |
11/2022 | DispatchHealth | Series E | 330M |
8/2012 | MyHealthTeams | Seed Round | 1.8M |
4/2014 | Boundary | Series C | 22M |
3/2017 | Visier | Series D | 0 |
2/2009 | Mpex Pharmaceuticals | Series D | 27.5M |
2/2006 | Cybera | Venture Round | 12.8M |
11/2016 | CareCloud Corporation | Series C | 31.5M |
4/2022 | Reify Health | Series D | 220M |
11/2015 | Earnest | Series B | 75M |
6/2010 | Adesto Technologies | Venture Round | 3.5M |
3/2013 | Q2ebanking | Series C | 20M |
2/2018 | Dynamic Signal | Series E | 0 |
9/2017 | Fusion Pharmaceuticals | Series A | 0 |
7/2004 | Danger | Series D | 37M |
4/2021 | ThreatQuotient | Debt Financing | 0 |
1/2022 | Dremio | Series E | 0 |
1/2016 | healthfinch | Series A | 7.5M |
2/2021 | PerimeterX | Series D | 0 |
10/2005 | Light Sciences Oncology | Series A | 35M |
1/2004 | E4 X Inc | Series C | 0 |
7/2012 | Borderfree | Series E | 0 |
5/2011 | Naurex | Series A | 18M |
11/2017 | ThreatQuotient | Series C | 30M |
4/2021 | Icosavax | Series B | 0 |
6/2022 | Nomad Health | Venture Round | 0 |
12/2010 | RetailMeNot | Series B | 90M |
8/2010 | YouSendIt | Series D | 15M |
11/2013 | Hightail | Series E | 0 |
1/2018 | MATRIXX Software | Series C | 0 |
4/2014 | Damballa | Series E | 13M |
8/2019 | MyHealthTeams | Series B | 0 |
8/2001 | Myogen | Series D | 52.4M |
8/2018 | Millendo Therapeutics | Venture Round | 30M |
1/2016 | Millendo Therapeutics | Series B | 0 |
9/2012 | Criteo | Series D | 40M |
4/2015 | Smule | Series F | 26M |
6/2021 | Visier | Series E | 125M |
3/2022 | BillionToOne | Series C | 0 |
3/2011 | Snagajob | Series C | 27M |
11/2015 | MyHealthTeams | Series A | 5M |
4/2022 | Remote | Series C | 0 |
1/2015 | Yeahka | Venture Round | - |
6/2010 | Incline Therapeutics | Series A | 43M |
11/2016 | Sauce Labs | Venture Round | 70M |
6/2002 | comScore | Series D | 20M |
4/2010 | Amonix | Series B | 0 |
11/2007 | RadPharm | Series B | 10M |
6/2021 | Iterable | Series E | 0 |
3/2009 | Neuraltus Pharmaceuticals | Series A | 17M |
11/2012 | ServiceMax | Series D | 27M |
8/2005 | Mpex Pharmaceuticals | Series B | 0 |
2/2010 | WebVisible | Series C | 20M |
7/2017 | Solera Health | Series B | 18.3M |
11/2014 | Bluprint | Series D | 50M |
7/2007 | Stratavia | Series B | 6.3M |
8/2005 | Stratavia | Series A | 3.3M |
10/2011 | MATRIXX Software | Series B | 12M |
1/2004 | Aesthera Corporation | Series A | 2.5M |
7/2022 | ClassDojo | Series D | 0 |
6/2022 | Nomad Health | Venture Round | 0 |
6/2022 | FalconX | Series D | 0 |
6/2022 | Mineralys Therapeutics | Series B | 0 |
4/2022 | Reify Health | Series D | 0 |
4/2022 | Remote | Series C | 0 |
3/2022 | BillionToOne | Series C | 0 |
1/2022 | Dremio | Series E | 0 |
10/2021 | Orca Security | Series C | 0 |
9/2021 | Nomad Health | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|